According to Royalty Pharma's latest financial reports the company's total liabilities are $6.29 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $6.29 B | -13.59% |
2022-12-31 | $7.28 B | 0.29% |
2021-12-31 | $7.26 B | 18.66% |
2020-12-31 | $6.12 B | -2.92% |
2019-12-31 | $6.30 B | -7.47% |
2018-12-31 | $6.81 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $34.38 B | 446.04% | ๐บ๐ธ USA |
Eli Lilly LLY | $51.04 B | 710.57% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $0.44 B | -92.90% | ๐บ๐ธ USA |